Phage therapy in people with cystic fibrosis: A systematic review
GastroenterologiaSobre o estudo
- Desenho
- Revisão sistemática
- Nível de evidência
- 1 · Evidência consolidada
- Revista
- International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
- Publicado em
- 23 mar 2026
- Citações
- 3
O resumo deste estudo é do publisher e não tem licença aberta: por isso mostramos aqui só os dados do estudo, e o texto fica na fonte original, nos links abaixo.
O estudo original
Phage therapy in people with cystic fibrosis: A systematic review
Vito Terlizzi, Giada Rinninella, Lucia Viglietto, Andrea D'Agosto, Mariagrazia Di Luca, Miquéias Lopes-Pacheco, Elena Chiappini
Descritores MeSH
- Cystic Fibrosis
- Pseudomonas Infections
- Phage Therapy
- Humans
- Pseudomonas aeruginosa
- Randomized Controlled Trials as Topic
- Treatment Outcome
- Drug Resistance, Multiple, Bacterial
- Adult
- Anti-Bacterial Agents
Veja também
Estudos relacionados
- Phage therapy with nebulized cocktail BX004-A for chronic Pseudomonas aeruginosa infections in cystic fibrosis: a randomized first-in-human trial
- Rising threats of ceftolozane-tazobactam resistance in P. aeruginosa and A. baumannii: Species-, phenotype-, and geography-specific insights from a systematic review and meta-analysis
- Mapping the knowledge landscape of Pseudomonas aeruginosa biofilm-mediated drug resistance: a bibliometric analysis and clinical trial landscape overview
- Comparison of ceftolozane-tazobactam and ceftazidime-avibactam for the treatment of infections caused by drug-resistant Pseudomonas aeruginosa: an updated systematic review and meta-analysis based on adjusted data from observational studies